Circadian clocks and neurodegenerative diseases: Time to aggregate?

Current Opinion in Neurobiology

Volumn 23, Issue 5, 2013, Pages 880-887

  Hastings, Michael H ^a   Goedert, Michel ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN;

BIOSYNTHESIS; BRAIN REGION; CATABOLISM; CELL FUNCTION; CELL METABOLISM; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; HUMAN; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN HOMEOSTASIS; REVIEW; SLEEP DISORDER; SLEEP PATTERN;

ANIMALS; BRAIN; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; HUMANS; NEURODEGENERATIVE DISEASES; SLEEP; WAKEFULNESS;

EID: 84884349765     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.05.004     Document Type: Review

References (70)

1. Goedert M., Clavaguera F., Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010, 33:317-325.
2. Harper D.G., et al. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry 2005, 13:359-368.
3. Hatfield C.F., Herbert J., Van Someren E.J., Hodges J.R., Hastings M.H. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004.
4. Hu K., Van Someren E.J., Shea S.A., Scheer F.A. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: involvement of the circadian pacemaker. Proc Natl Acad Sci U S A 2009, 106:2490-2494.
5. Bliwise D.L., et al. Sleep disturbance in dementia with Lewy bodies and Alzheimer's disease: a multicenter analysis. Dement Geriatr Cogn Disord 2011, 31:239-246.
6. Morton A.J., et al. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci 2005, 25:157-163.
7. Goodman A.O.G., Barker R.A. How vital is sleep in Huntington's disease?. J Neurol 2010, 257:882-897.
8. Simpson C., Carter P.A. Pilot study of a brief behavioral sleep intervention for caregivers of individuals with dementia. Res Geront Nurs 2010, 3:19-29.
9. Harper D.G., et al. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain 2008, 131(Pt 6):1609-1617.
10. Singletary K.G., Naidoo N. Disease and degeneration of aging neural systems that integrate sleep drive and circadian oscillations. Front Neurol 2011, 2:66.
11. Braak H., Del Tredici K. Alzheimer's pathogenesis: is there neuron-to-neuron propagation?. Acta Neuropathol 2011, 121:589-595.
12. Adamantidis A., Carter M.C., de Lecea L. Optogenetic deconstruction of sleep-wake circuitry in the brain. Front Mol Neurosci 2010, 2:31.
13. Schenck C.H., Bundlie S.R., Ettinger M.G., Mahowald M.W. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986, 9:293-308.
14. Boeve B.F. Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol 2013, 12:469-482.
15. Iranzo A., et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 2013.
16. Pallier P.N., et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J Neurosci 2007, 27:7869-7878.
17. Maywood E.S., et al. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J Neurosci 2010, 30:10199-10204.
18. Riemersma-van der Lek R.F., et al. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 2008, 299:2642-2655.
19. Lieverse R., et al. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry 2011, 68:61-70.
20. Huang N., et al. Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex. Science 2012, 337:189-194.
21. Koike N., et al. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science 2012, 338:349-354.
22. Akhtar R.A., et al. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 2002, 12:540-550.
23. Panda S., et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002, 109:307-320.
24. Reddy A.B., et al. Circadian orchestration of the hepatic proteome. Curr Biol 2006, 16:1107-1115.
25. Deery M.J., et al. Proteomic analysis reveals the role of synaptic vesicle cycling in sustaining the suprachiasmatic circadian clock. Curr Biol 2009, 19:2031-2036.
26. Thome J., Coogan A.N., Woods A.G., Darie C.C., Hassler F. CLOCK genes and circadian rhythmicity in Alzheimer disease. J Aging Res 2011, 383091.
27. Yesavage J.A., et al. Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease. Am J Geriatr Psychiatry 2011, 19:635-643.
28. Cermakian N., Lamont E.W., Boudreau P., Boivin D.B. Circadian clock gene expression in brain regions of Alzheimer's disease patients and control subjects. J Biol Rhythms 2011, 26:160-170.
29. Ittner L.M., Götz J. Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 2011, 12:65-72.
30. Clavaguera F., et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009, 11:909-913.
31. Nussbaum J.M., et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature 2012, 485:651-655.
32. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008, 14:504-506.
33. Kordower J.H., Chu Y., Hauser R.A., Olanow C.W., Freeman T.B. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Move Disorders 2008, 23:2303-2306.
34. Li J.Y., et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008, 14:501-503.
35. Federico A., et al. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 2012, 322:254-262.
36. Menzies F.M., Moreau K., Rubinsztein D.C. Protein misfolding disorders and macroautophagy. Curr Opin Cell Biol 2011, 23:190-197.
37. Schaeffer V., et al. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 2012, 135(Pt 7):2169-2177.
38. Martinez-Vicente M., et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 2008, 118:777-788.
39. Tanik S.A., Schultheiss C.E., Volpicelli-Daley L.A., Brunden K.R., Lee V.M. Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem 2013, 24:15194-15210.
40. Winslow A.R., et al. alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 2010, 190:1023-1037.
41. Pizarro A., Hayer K., Lahens N.F., Hogenesch J.B. CircaDB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res 2013, 41(Database issue):D1009-D1013.
42. Belanger V., Picard N., Cermakian N. The circadian regulation of Presenilin-2 gene expression. Chronobiol Int 2006, 23:747-766.
43. Singleton A.B., et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
44. Chartier-Harlin M.C., et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
45. Ibanez P., et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004, 364:1169-1171.
46. Satake W., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009, 41:1303-1307.
47. Simon-Sanchez J., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009, 41:1308-1312.
48. Scholz S.W., et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009, 65:610-614.
49. Sachdeva U.M., Thompson C.B. Diurnal rhythms of autophagy: implications for cell biology and human disease. Autophagy 2008, 4:581-589.
50. Ma D., Panda S., Lin J.D. Temporal orchestration of circadian autophagy rhythm by C/EBPbeta. EMBO J 2011, 30:4642-4651.
51. Godinho S.I., et al. The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science 2007, 316:897-900.
52. Hirota T., et al. Identification of small molecule activators of cryptochrome. Science 2012, 337:1094-1097.
53. Kondratova A.A., Kondratov R.V. The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 2012, 13:325-335.
54. Edgar R.S., et al. Peroxiredoxins are conserved markers of circadian rhythms. Nature 2012, 485:459-464.
55. Goedert M., et al. The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A 1993, 90:5066-5070.
56. Arendt T., et al. Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 2003, 23:6972-6981.
57. Stieler J.T., et al. The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation. PLoS ONE 2011, 6:e14530.
58. Planel E., et al. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 2004, 24:2401-2411.
59. Gallego M., Virshup D.M. Post-translational modifications regulate the ticking of the circadian clock. Nat Rev Mol Cell Biol 2007, 8:139-148.
60. Gong C.X., Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 1993, 61:921-927.
61. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 2001, 168:402-412.
62. Brown S.A., Zumbrunn G., Fleury-Olela F., Preitner N., Schibler U. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr Biol 2002, 12:1574-1583.
63. Dossena S., et al. Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 2008, 60:598-609.
64. Zhang B., et al. Fatal familial insomnia: a middle-age-onset Chinese family kindred. Sleep Med 2010, 11:498-499.
65. Tobler I., et al. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 1996, 380:639-642.
66. Cagampang F.R., et al. Circadian regulation of prion protein messenger RNA in the rat forebrain: a widespread and synchronous rhythm. Neuroscience 1999, 91:1201-1204.
67. Kang J.E., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009, 326:1005-1007.
68. Ju Y.E., et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol 2013, 1-7.
69. Roh J.H., et al. Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 2012, 4:150ra122.
70. Goodman A.O., et al. Asymptomatic sleep abnormalities are a common early feature in patients with Huntington's disease. Curr Neurol Neurosci Rep 2011, 11:211-217.